OHB's Orbital Milestones Pile Up, but the Market Is Fixated on the Margin Story

OHB shares closed at EUR 158.40, down 13% over 30 days, as investors await 12 November nine-month results for margin and cash flow clarity.

Bremen's OHB SE has spent the autumn doing what space companies are supposed to do: launching hardware, completing constellations, and reshuffling leadership at its rocket unit. What it has not done is convince the equity market to reward any of it. With the nine-month report due on 12 November 2026, alongside a presentation for analysts, the gap between operational progress and share-price performance has become the central question facing investors.

The stock closed Friday at EUR 158.40. Over the past 30 days it has shed 13 percent, and it now trades roughly 40 percent below its 200-day moving average — a technical picture that sits awkwardly beside a year-to-date gain of 35 percent. That divergence is the puzzle: the technology keeps delivering, yet the valuation keeps drifting.

Hardware on schedule, sentiment on hold

Two project milestones stand out. Just over a week ago, the ATHENE-1 technology demonstrator lifted off aboard a Falcon 9 rocket, reaching low Earth orbit to host 22 experiments spanning satellite communications and data processing. Roughly two weeks before that, subsidiary OHB Italia wrapped up the Eaglet-II constellation for Italy's IRIDE Earth-observation programme, bringing the series to its planned total of 24 satellites.

Both achievements landed on time. Neither moved the needle on the screen.

The explanation lies less in orbit than in the income statement. Building satellites and launch vehicles is capital-hungry, and the market's attention has shifted to how efficiently OHB converts its backlog into earnings. Operating margin and cash flow, rather than mission success, are what will set the tone for the remainder of the year.

That focus sharpens the significance of a recent boardroom change. About a week ago, the supervisory board of subsidiary Rocket Factory Augsburg appointed Alexander Dahm as its new chief executive, tasking him with steering the company toward the maiden flight of the RFA ONE launcher. Development programmes of that kind consume cash and demand tight cost discipline — and any slippage in the RFA ONE timeline would carry meaningful cost implications for the group.

Fixed-price exposure and a trimmed anchor stake

The structural risks are familiar to anyone who follows the sector: supplier delays, integration snags, and expensive launch postponements. Under fixed-price contracts in the institutional business, budget overruns feed straight into margins. Whether group earnings keep pace with the expansion of activities will hinge on how cleanly those large orders are executed.

On the shareholder register, control remains firmly with the founding Fuchs family. Financial investor KKR, holding its stake through Orchid Lux HoldCo S.à r.l., sits as a minority shareholder after acting as a seller of existing shares in a capital increase — a move that trimmed its position to around 20 percent, as disclosed in the half-year report. A major holder lightening its exposure while the stock trades well below its 200-day average has done little to bolster confidence among prospective new buyers.

The bull case still has a floor

Not everything points downward. The punctual completion of complex satellite series such as IRIDE demonstrates OHB's industrial capability in a European market for space and security infrastructure that continues to expand. The stock's admission to the TecDAX selection index — announced on 21 September following a review by index provider STOXX — adds visibility among large institutional investors.

Analyst support reinforces that view. On 29 September, Michael Filatov of Berenberg reiterated his buy rating and left his price target unchanged at EUR 358.

Should the coming figures show stable supply chains and delivery against profitability targets, the shares would have substantial room for a re-rating from current levels. Dependable project execution, free of one-off charges, would go a long way toward restoring market confidence.

November 12 is the pivot

The direction for the coming months now rests on hard company data. As long as the stock holds its present level and no negative news emerges from ongoing projects, the recovery scenario remains a valid reference point. If operating performance deteriorates instead — through unexpected margin pressure or rising development costs at the subsidiaries — the downward move could resume, since investors would likely demand a wider risk premium.

The catalyst is already on the calendar. On 12 November 2026, OHB publishes its third-quarter and nine-month results, with an accompanying earnings presentation that should give shareholders the evidence they need to weigh genuine earning power against the project risks still in play.